Member Info for Vascular

Anyone noticed the charts yesterday before close and again this morning. It looks to me someone is either accumulating or selling between 49.8 and 495. Its hard for me to see as they are a mix of reds and greens, but all within these limits.

Interesting that Farmaline, who also work closer with Coopers have around 60 reviews of Eroxon presently ( same as Boots).
https://www.farmaline.be/apotheek/bestellen/eroxon/

I did not realise that Vemedia, was owned by Coopers Health and they supply 80,000 chemists in Europe!
They also have 2 m monthly customers online!!
This makes the Boots 2,200 stores in UK, )look rather small fry.
This from a day ago.
https://www.linkedin.com/company/vemedia-consumer-health-belux/?originalSubdomain=be

With many new products these days they use social influencers , some have millions of followers so to promote a new product. These influencers usually discuss the product in their chats, and/ or review it or are just seen using the product....I just cant see a celebrity willing to admit they may have a ED, or confidence issue, nor be filmed using it LOl.

Top Instagram Influencers in United Kingdom in 2023

Priyanka @priyankachopr United Kingdom 86.5M
Manchester United United Kingdom Soccer 61.6M
Ed Sheeran United Kingdom Singer 43.3M

https://starngage.com/app/global/influencer/ranking/united-kingdom

Sorry, my point being that with equivalent of 16.5 million men in UK, suffering what they feel is ED and only £13 million spent on prescriptions by NHS each year , there is a massive amount of men falling through the gap here.


The market is so much bigger than the ED prescription pill market but the public , men and women need to educated somehow.

Many women will be just as aware of their partners situation, and are IMO more likely to buy this product in a shop for their partner, to try.

Its good to have a presence on the high-street but unless someone is actually looking for a product then it will never sell.

I think with most products the customer needs to be educated first, then they go in search for the product online, or in brick and mortar shops, locally - and that is particularly important with a product like Eroxon because it is the first of its kind, no one will be looking for it unless they have been educated about it in the first place - as up until a week ago a OTC cream for ED was not available in the shops in UK.

Added to this dilemma is the fact that buying an ED cream, for many is embarrassing . Its not like buying condoms, play oils as these are just used as safe, or fun addition to having sex. Buying Eroxon, the ED cream is disclosing what could be perceived as a weakness, personal failure and most people do not like to disclose such information, so publicly. etc .

So IMO there are two markets.

The ED market
The youngsters / younger men market , whom can add the gel with their Condon when going out for night, hoping to get lucky / confidence gel.

Its how do you educate the UK population that this gel actually exists, is available to try. The last week has relied upon the publicity, which will tail off unless something replaces it.

Have a look at these statistics. Quite amazing and sad really
https://pharmacydirectgb.co.uk/erectile-dysfunction-statistics-facts-figures-in-the-uk-in-2021/#:~:text=Erectile%20Dysfunction%20is%20experienced%20by,are%20affected%20by%20the%20conditi

With over 60% of users reviews giving excellent results , and approx. 40% stating its did not work for them, surely if these percentages turn out to be accurate then this product will be a massive hit.

If we can maintain approx. 60% of users happy with product, with no side effects, then they are sure to use it regularly, as its will be the solutions to their problem.

Just for fun. i looked up whta are boots top five selling products and one of them is Clinique Dramatically Different Moisturizing Lotion+™.

There are approx. 400 user reviews, with approx. 65% giving 5, or 4 stars. with 20 people buying in past 24 hours.

So even though we do not now the sales rate of each product , they are generally on a par with user satisfaction and disappointment. Seems to me that even with one of Boots best sellers there is a approx. 40% negative reviews.

Just a thought.

IMO The January presentation by Tom, is key here. I think more patience is required. I have now listened to this several times and each time hear something new.

Here are my highlights form the presentation to do with India.
Remember time has moved on, and between June and September the Bleepa product could well be licensed in India as a medical product and for sale.

Tom states "We are in a "CONSORTIUM" with Amazon and Qure.AI and in discussions with some large Telco players in India !!!, so to access the cloud in remote areas in India."
Also seeing opportunities in India with "individual private hospitals and at a more regional level, with state level governments" in connecting state government, and to quote again " all these conversations are on the way, but unfortunately can't be realised until Bleepa has the medical imaging licence completed, six to nine months ( maybe June to September 23!)

CareLocker is just beginning, and as far as India is concerned is the nearer term opportunity and they already have interest from many other cities, in India other than Indore. To quote Tom "the Scale of this is truly enormous", as each individual imaging centre will save money selling the scan, to the patient , and larger the town or city the more diagnostic centres exist. "Indore has 40 imaging centres , larger cities have hundreds..".

I really like the fact that Tom stated that FDBK are in consortium with Qure.ai and Amazon in India....massive potential, in India alone.

The UK, will also come good too, just i think they are even more tied up in non disclosure, than they are in India.

Quote from presentation again . In UK " they are not dependent on the CDCs being completed, they can provide the technology for joined up working long before the actual CDCs are completed.".

I take from this that FDBKs offering is an easy fruit, relatively cheap and effective , which will change the landscape of the way the NHS communicates, even before they have completed the CDCs.

I think the share price is taking a breather, and needs these periodic retraces to clear the decks. Obviously the fda is the big news on the horizon, and will be the next leg up, but also we have been promised retrospective news releases of new distribution channels at any time, here in UK, and in Europe and other continents....

My gut tells me that once the fda decision is public, and all ok, it should be good news from here on, as we enjoy increasing news regarding the availability of the product across a large, prosperous chunk of the world and subsequent increasing revenues. As long as the fda come out good, and the product sells and gains a loyal following...its hard to see any negatives, which is rare as aim is a snake pit,....if this is the case , our only real enemy is time, and limited patience, as the company is allowed to develop.

I an no expert either. There are a few on this BB who may be able to explain more.

All i take from this so far is that there is presently no mining act agreement in Malawi, they are between the old act and the consideration of a new one = a massive government led upheaval involving voting through a draft of a new mining act (23) , with the very real possibility of it being kicked out of parliament and put back to more consultation . If it gets through it will have to go through a number of regularly committees to ratify it etc ..before being made law.

My gut feeling is its about money, its about future royalty's that a sovereign state like Malawi will charge for the rights to mine, drill etc and most importantly to make it more transparent to the public and the Malawi government ( whom in the past where not allowed access to certain information on mining deals , supposedly due to the nature of confidentiality). This way of doing business was a front for, and encouraged a lot of bribery, corruption and stealing of state monies (revenues) by individuals and organisations.

If they are serious and wish to clean up their act then i cant see them nodding through any new large mining contracts before this is resolved. But what do I know! Just a hunch.

Finton, more here.

https://www.opengovpartnership.org/members/malawi/commitments/MW0010/

there are several other Government commitments listed at bottom of page

Finton. This is a recent account.

What is means for Mkango, anyone's guess.

https://allafrica.com/stories/202304120195.html

repeated its ‘buy’ recommendation and 121p a share price target for the stock in early April 23.
They also state ...
“Encouragingly, as the launch of Eroxon builds in Europe, Futura expects to generate maiden commercial revenues this year.
Given the lack of visibility with regards to either timing or quantum of these revenues, we haven’t yet factored them into our forecasts, but these, together with other potential sources of income mean that we are very comfortable that Futura is well funded to deliver without needing to turn to equity markets,” said Liberum in a note to clients."

So the broker thought that £1.21 was a realistic share price target , without revenue.

What share price target will they come up with now that the rollout across UK & Europe has begun , and will increase incrementally as each new region starts contributing revenue.

The North East Commissioning Group tender for Nirth % South Tynsude closed today at noon. I would be surprised if FDBK did not take part.
So possibility of some positive news soon if they announce it quicker than the other recent tenders.

How about a branded Erexon condom, with a separate pot of gel, for £6. It would be like being able to buy a condom with a little blue tablet and very tempting for the youngsters who probably have more sex that the oldies. lol.

Anyway, a very exciting product and now out!

Buffaloben. This is what i am trying to get my head around...the more i think about potential , the more the opportunities seem to appear.

People are not stupid, and potential customers of all ages can immediately see how a OTC product that helps ED, may also give them (( those without ED) that extra lift, assurance and confidence in their endeavours on the night.

Assuming most condoms are bought by people who are not in a steady long term relationship, then this would be a fantastic add on.
Possibly lending to one day, a condom with the gel already included for foreplay, sold in singles and multi packs so youngers can afford it also.

As far as the number of possible outlets go, ( not including online), then being non prescriptive, over the counter with minimal side effects then even GPs may recommended patients give it a try before taking prescriptions , for the pill solutions.
I guess that at the end of the day it would rely on the general public becoming aware of the name Erexon, and what it is, and what it does - just the same as the public discovering and learning about Viagra 25 years ago...

Publicity is everything here i think, and so far the company have done well with the UK launch, but its only day two as you say and this will need to be continued...

Many companies now rely on celebrity endorsements, celebrities with like 1- 10 million followers to promote their products to their followers....i think finding a celebrity , who admits to needing a little help in the bedroom may be a tough call....but there may be some, of a certain age that could do this ...and that would be a fast track to sales.

Question for the more researched here.

If you look at Durex as a product , it is presently sold in Asda, Tesco, Morrisons, Boots, M&S and many others.....10s of millions of regular supermarket customers, and again 10s of millions of reward card holders...

Is there any reason why Eroxon could not be sold alongside the durex products as either ED solution / young male confidence sauce/ foreplay oil in supermarkets in UK in the future.

Once the public are aware of the products existence, surely their is a natural synergy and a place on the condon shelf for this product..

I am talking UK, but similar goes for Europe and possibly US.

I am hoping we have a leaky ship...as i do not mind leaky if it works in my favour, but that's probably just me hallucinating brought on by frustration :)

Had a quick look at the so called AIM rule book ,for a DT 5 which is a bit of a joke.
The definition is below but IMO the key moment sentence to look out for is "following receipt of the notification.".

So there is the outside chance that FDBK have not yet been notified by the buyer of these shares ...and once they are notified will need to release a RNS by end of NEXT trading day.

"Under DTR 5 a person who holds voting rights in a UK AIM company (as a shareholder or through direct/indirect holding of financial instruments) must notify the company when those voting rights reach, exceed or fall below 3% and each 1% threshold thereafter. The AIM company must disclose to the market all information received in a notification to it under DTR 5 as soon as possible and in any event by the end of the next trading day following receipt of the notification."

Boots are being suppled / distributed too by Coopers.....This is presently the only distribution agreement in UK. Does anyone know if Coopers will in future go on to distribute to other shop chains in UK, or will Futura Medical need to find another distribution company to access other retail outlets.